{{Rsnum
|rsid=6503691
|Gene=STAT5B
|Chromosome=17
|position=42242072
|Orientation=plus
|GMAF=0.27
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=STAT5B
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 78.6 | 21.4 | 0.0
| HCB | 58.4 | 36.5 | 5.1
| JPT | 47.8 | 44.2 | 8.0
| YRI | 8.2 | 42.9 | 49.0
| ASW | 28.6 | 50.0 | 21.4
| CHB | 58.4 | 36.5 | 5.1
| CHD | 54.1 | 38.5 | 7.3
| GIH | 50.5 | 40.6 | 8.9
| LWK | 4.5 | 39.1 | 56.4
| MEX | 79.3 | 17.2 | 3.4
| MKK | 17.3 | 50.6 | 32.1
| TSI | 77.5 | 20.6 | 2.0
| HapMapRevision=28
}}{{PMID|17639043}} [[breast cancer]]

[[rs6503691]] [[rs7211777]] Carriers of the AC haplotype, which represents the variant alleles of both SNPs, were at an increased risk (OR = 1.41, 95% CI 1.09-1.82). A decreased risk was observed for carriers of the AT haplotype (OR = 0.60, 95% CI 0.38-0.94). Furthermore, individuals with the AC/GC diplotype were at a significantly increased risk (OR = 1.88, 95% CI 1.13-3.14)

{{PMID Auto
|PMID=21470284
|Title=The signal transducer and activator of transcription 5B gene polymorphism contributes to the cholesterol metabolism in Japanese children with growth hormone deficiency
}}

{{PMID|20065083|OA=1
}} A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon alpha.

{{PMID|21668356}} Association of signal transducer and activator of transcription 3 gene polymorphisms with cervical cancer in Chinese women.

{{PMID|21948258}} Association between polymorphisms in the signal transducer and activator of transcription and dilated cardiomyopathy in the Chinese Han population.

{{PMID Auto
|PMID=23130760
|Title=No association between the STAT5b rs6503691 (C&gt;T) SNP and myeloproliferative neoplasms
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}